Home > Keywords >
Catalog | name | Description | price |
---|---|---|---|
R-C-2730 | MK-8245 CAS:1030612-90-8 | MK-8245 is an liver-targeting inhibitor of stearoyl-CoA desaturase (SCD)with IC50 of 1 nM for human SCD1 and 3nM for both rat SCD1 and mouse SCD1,with anti-diabetic and anti-dyslipidemic efficacy.Phase 2. | price> |
R-R-4430 | Lartesertib CAS No.2495096-26-7 | Lartesertib (M4076)/CAS No.2495096-26-7 is a potent inhibitor of serine/threonine protein kinase ATM (extracted from patent WO2022058351A1). | price> |
R-C-2731 | ABT-046 CAS:1031336-60-3 | ABT-046 is a potent,selective,and orally efficacious acyl CoA:diacylglycerol acyltransferase 1(DGAT-1)inhibitor(IC50=8nM). | price> |
R-R-4431 | Ro 90-7501 CAS No.293762-45-5 | Ro 90-7501/CAS No.293762-45-5 is an amyloid β42 (Aβ42) fibril assembly inhibitor that reduces Aβ42-induced cytotoxicity (EC50 of 2 μM). Ro 90-7501 inhibits ATM phosphorylation and DNA repair. RO 90-7501 selectively enhances toll-like receptor 3 (TLR3) and RIG-I-like receptor (RLR) ligand-induced IFN-β gene expression and antiviral response. Ro 90-7501 also inhibits protein phosphatase 5 (PP5) in a TPR-dependent manner. Ro 90-7501 has significant radiosensitizing effects on cervical cancer cells. | price> |
R-C-2732 | CS@Fe3O4 nanoparticles | The product is 30nm chitosan coated Fe3O4 magnetic nanoparticles with a large number of active amino groups on the surface and a saturation magnetization of 70-80. | price> |
R-R-4432 | (S)-Ceralasertib CAS No.1352226-87-9 | (S)-Ceralasertib ((S)-AZD6738)/CAS No.1352226-87-9 is extracted from patent WO2011154737A1, Compound II, exhibits an IC50 of 2.578 nM. (S)-Ceralasertib is a potent and selective sulfoximine morpholinopyrimidine ATR inhibitor with excellent preclinical physicochemical and pharmacokinetic (PK) characteristics. (S)-Ceralasertib is developed improving aqueous solubility and eliminates CYP3A4 time-dependent inhibition. | price> |
R-C-2733 | MPPC | Pharmaceutical excipients,synthetic phospholipids(1-myristoyl-2-palmitoyl-sn-glycoro-3-phosphotidylcholine)were customized and synthesized in Ruixi BiotechCo.,Ltd. | price> |
R-R-4433 | AZ32 CAS No.2288709-96-4 | AZ32/CAS No.2288709-96-4 is an orally bioavailable and blood-brain barrier-penetrating ATM inhibitor with an IC50 of <6.2 nM for ATM enzyme, and an IC50 of 0.31 μM for ATM in cell. | price> |
R-C-2734 | A939572 CAS:1032229-33-6 | A939572 is a potent,and orally bioavailable stearoyl-CoA desaturase1(SCD1)inhibitor with IC50 values of <4nM and 37nM for mSCD1 and hSCD1,respectively. | price> |
R-R-4434 | NU6027 CAS No.220036-08-8 | NU6027/CAS No.220036-08-8 is a potent and ATP-competitive inhibitor of both CDK1 and CDK2, with Kis of 2.5 µM and 1.3 µM, respectively. NU6027 is also a potent inhibitor of ATR and enhances hydroxyurea and cisplatin cytotoxicity in an ATR-dependent manner. | price> |
R-C-2735 | Telotristat CAS:1033805-28-5 | Telotristat(LP-778902)is the acid form of Telotristat ethyl,and the active metabolite of LX1606(Telotristat etiprate),which is an orally bioavailable, small-molecule,tryptophan hydroxylase(TPH)inhibitor and serotonin synthesis inhibitor with potential antiserotonergic activity. | price> |
R-R-4435 | Elimusertib-d3 | Elimusertib-d3 (BAY 1895344-d3) is the deuterium labeled Elimusertib (BAY 1895344). Elimusertib is a potent, orally active and selective ATR inhibitor and has anti-tumor activity. | price> |
R-C-2736 | Dafadine-A CAS:1065506-69-5 | Dafadine-A,an analog of dafadine, is a novel inhibitor of DAF-9 cytochrome P450 in the nematode Caenorhabditis elegans; also inhibits the mammalian ortholog of DAF-9(CYP27A1). | price> |
R-R-4436 | KU 59403 CAS No.845932-30-1 | KU 59403/CAS No.845932-30-1 is a potent ATM inhibitor, with IC50 values of 3 nM, 9.1 μM and 10 μM for ATM, DNA-PK and PI3K, respectively. | price> |
R-C-2737 | Indoximod (NLG-8189) CAS:110117-83-4 | Indoximod(1-Methyl-D-tryptophan;NLG-8189)is an indoleamine 2,3-dioxygenase(IDO)pathway inhibitor with a Ki of 19μM. | price> |
R-R-4437 | SKLB-197 CAS No.2713577-16-1 | SKLB-197/CAS No.2713577-16-1 showed an IC50 value of 0.013 μM against ATR but very weak or no activity against other 402 protein kinases. It displayed potent antitumor activity against ATM-deficent tumors both in vitro and in vivo. | price> |
R-C-2738 | Tunicamycin CAS:11089-65-9 | Tunicamycin is a mixture of homologous nucleoside antibiotic that inhibits N-linked glycosylation and blocks GlcNAc phosphotransferase(GPT).Tunicamycin causes accumulation of unfolded proteins in cell endoplasmic reticulum(ER)and induces ER stress,and causes blocking of DNA synthesis and cell cycle arrest in G1 phase. | price> |
R-R-4438 | ATR-IN-4 CAS No.2574545-45-0 | ATR-IN-4/CAS No.2574545-45-0 is a potent ATR (Ataxia telangiectasia mutated gene Rad 3-associated kinase) inhibitor. ATR-IN-4 inhibits growth of human prostate cancer cells DU145 and human lung cancer cells NCI-H460 with IC50s of 130.9 nM and 41 .33 nM, respectively. (Patent CN112142744A, compound 13). | price> |
R-C-2739 | PF-04620110 CAS:1109276-89-2 | PF-04620110 is a potent,selective and orally bioavailable diglyceride acyltransferase-1(DGAT-1)inhibitor with an IC50 of 19nM. | price> |
R-R-4439 | Tozasertib CAS No.639089-54-6 | Tozasertib (VX 680; MK-0457)/CAS No.639089-54-6 is an inhibitor of Aurora A/B/C kinases with Kis of 0.6, 18, 4.6 nM, respectively. | price> |